Evidence map›Paper›PMID 39472412›Full record

ArticleClinical rheumatology2024

Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis.

Diego Fernando Rojas-Gualdrón, Carolina Franco-Salazar, Clara Ángela Gómez-Henck, Maria Camila Manrique-Castrillón, Yennifer Carime Hoyos-Méndez, Susana Vélez-Romero, Juan Camilo Díaz-Coronado

Abstract read
In one paragraph

Article in Clinical rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diego Fernando Rojas-GualdrónFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia. dfrojas@ces.edu.co.ORCID http://orcid.org/0000-0002-2293-0431
Carolina Franco-SalazarFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0009-0001-7618-2889
Clara Ángela Gómez-HenckFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0000-0003-0848-8330
Maria Camila Manrique-CastrillónFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0000-0003-1463-1375
Yennifer Carime Hoyos-MéndezFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0000-0002-1991-5820
Susana Vélez-RomeroFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0000-0001-6777-2150
Juan Camilo Díaz-CoronadoFacultad de Medicina, Universidad CES, Calle 10ª # 22-04 Bloque C Piso 2, Medellín, Colombia.ORCID http://orcid.org/0000-0001-7695-7253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the HRQoL loss associated with self-perceived anxiety/depression in patients with seropositive rheumatoid arthritis (RA).

methodThis secondary data analysis is based on a registry-based retrospective follow-up study of patients with seropositive RA treated between August 2014 and January 2023 in ARTMEDICA, Colombia. HRQoL loss and self-perceived anxiety/depression were defined as outcomes. Disease activity (DAS-28) and other patient data were also gathered. Statistical analyses were performed using the ordinal logistic and generalized linear regression models.

resultsA total of 3579 patients with a mean follow-up of 2.9 (SD 2.4) years, 85.6% women with a median age at diagnosis of 48.1 (IQR 37.8-57.5) years, and a median of 6.5 (IQR 1.9-14.7) years living with RA were included. At program admission, the median DAS-28 score was 2.8 (IQR 2.1-4.2), and 6.6% of patients reported extreme anxiety/depression. The average HRQoL loss was 3.4 months per year lived with seropositive AR. Among patients with no pain or discomfort, moderate and extreme anxiety/depression were associated with mean HRQoL losses of 2.2 (95% CI - 2.3 to - 2.2) and 4.1 (95% CI - 4.3 to - 3.8) months. In patients with extreme pain/discomfort, these estimations were 0.8 (95% CI - 0.9 to - 0.7) and 1.9 (95% CI - 2.1 to - 1.7) months, respectively.

conclusionOur study adds to the available body of evidence by clarifying the differential impact of anxiety/depression on HRQoL, depending on the severity of pain. These findings highlight the importance of strengthening mental health care and psychological well-being interventions for patients with RA, regardless of pain or disease activity. Key Points • The average HRQoL loss was 3.4 months per year lived with seropositive AR. • Pain/discomfort rather than disease activity explained the severity of anxiety/depression as well as its associated HRQoL loss. • For patients with extreme pain/discomfort and anxiety/depression, the average HRQoL loss was 8.1 months per year lived with the disease compared to 0.4 months for patients without those impacts.

Indexed as

AnxietyArthritis, RheumatoidDepressionQuality of LifeAdultColombiaFemaleFollow-Up StudiesHumansMaleMiddle AgedRegistriesRetrospective StudiesSeverity of Illness IndexAnxietyArthritisDepressionQuality-adjusted life yearsRheumatoid

Identifiers

PMID39472412
PMCPMC11582188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.